120
Participants
Start Date
December 13, 2023
Primary Completion Date
April 17, 2024
Study Completion Date
April 22, 2024
Data collection
Participants were identified by reviewing electronic medical records. Medical history information of thyroid disease and associated medication were collected in both groups, as well as a history of other comorbidities such as diabetes mellitus type 2, arterial hypertension, dyslipidemia, anxiety, and depression. Cases and controls were matched by age and sex.
Campus Bellvitge, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, L'Hospitalet de Llobregat
University of Barcelona
OTHER